BSW Wealth Partners
Source: SEC Form 13F · as of Mar 2026BSW Wealth Partners holds 18 biotech & pharma companies tracked by BioSniper, totaling $19.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
18
Total value held
$19.3M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 3,463 | $3.2M |
| ABBVAbbVie Inc. | 10,496 | $2.3M |
| MRKMerck & Co., Inc. | 17,994 | $2.2M |
| PFEPFIZER INC | 67,473 | $1.9M |
| JNJJOHNSON & JOHNSON | 5,492 | $1.3M |
| ABTABBOTT LABORATORIES | 11,988 | $1.2M |
| AMGNAMGEN INC | 2,714 | $955K |
| GILDGILEAD SCIENCES, INC. | 6,293 | $877K |
| BMYBRISTOL MYERS SQUIBB CO | 13,391 | $812K |
| PMPhilip Morris International Inc | 4,459 | $737K |
| NAGENiagen Bioscience, Inc. | 154,000 | $679K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 2,365 | $640K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 10,446 | $577K |
| NVSNovartis AG | 2,772 | $423K |
| REGNREGENERON PHARMACEUTICALS, INC. | 518 | $400K |
| SNYSanofi | 8,133 | $392K |
| BIIBBIOGEN INC. | 2,074 | $380K |
| TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | 15,831 | $293K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.